Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs.
Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs. A Two Phases Study, Part of STOP OM PROJECT. Phase 2, Single Arm, Interventional, Longitudinal, Clinical Trial.
Mucosa Innovations, S.L.
63 participants
Oct 11, 2022
INTERVENTIONAL
Conditions
Summary
The use of a novel topical mucosa composition (XCM-OM118) comprising 2-(trimethylazaniumyl) acetate; (2R,3R,4S)-pentane-1,2,3,4,5-pentol; Hexadecanoic acid; (9Z, 12Z)-octadeca-9,12-dienoic acid; octadecanoic acid; (Z)-hexadec-9-enoic acid; (Z)-octadec-9-enoic acid) delivered as a gel and a mouthwash is to be studied in regard to its effect on the incidence of severe oral mucositis in Head \& Neck cancer radiated patients. Patient reported outcome measures seem to be an effective tool to obtain a greater knowledge of the physical and emotional state of patients, being used in this study to assess quality of life of Head \& Neck cancer radiated patients.
Eligibility
Inclusion Criteria8
- Acute Phase
- Patients diagnosed with Head \& Neck cancer who will undergo radiotherapy (with or without concomitant chemotherapy)
- Patients who are able to read, understand, and complete the questionnaire.
- Patients over 18 years of age.
- Chronic Phase
- Patients who have completed radiotherapy treatment at least 6 months before study enrollement.
- Patients who are able to read, understand, and complete the questionnaire.
- Patients over 18 years of age.
Exclusion Criteria7
- Acute Phase
- Patients who are unable to properly use the products.
- Patients who do not consent to participate in the study.
- Patients who were being treated for another type of cancer.
- Chronic Phase
- Patients using medications such as pilocarpine, cevimeline, etc., to treat xerostomia.
- Patients who do not consent to participate in the study.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Topical composition in the form of a gel and a mouthwash.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05635929